In this podcast, Mark Penessi (USA) is joined by Isabelle Audo (FRANCE) and Bart Leroy (BELGIUM) to discuss the impact of Luxturna and how gene therapy products will affect the treatment of inherited retinal diseases (IRD) in the future.
Members can continue the conversation in the EURETINA Forum.
Browse all podcast episodes here.
Listen on your preferred podcast player:
